HLA-G gene editing in tumor cell lines as a novel alternative in cancer immunotherapy

Abstract Cancer immunotherapies based mainly on the blockade of immune-checkpoint (IC) molecules by anti-IC antibodies offer new alternatives for treatment in oncological diseases. However, a considerable proportion of patients remain unresponsive to them. Hence, the development of novel clinical im...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: María Belén Palma, Diana Tronik-Le Roux, Guadalupe Amín, Sheila Castañeda, Alan M. Möbbs, María Agustina Scarafia, Alejandro La Greca, Marina Daouya, Isabelle Poras, Ana María Inda, Lucía N. Moro, Edgardo D. Carosella, Marcela N. García, Santiago G. Miriuka
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/894a26ff5d8c49e7b84811e2e58054c0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!